GLP-1 preparation videos: what TikTok gets right and wrong

What did @maisagoranews actually say?

Honestly? It's nearly impossible to tell. The transcript is a string of incoherent phrases, including references to "pseudob Cambodian," something called "Goldilent," a "biennial" bubble, and repeated mentions of an entity called "UPLAC." None of these correspond to any recognized GLP-1 terminology, medication names, or clinical concepts. No verifiable claim was made.

The video was tagged as a GLP-1 educational post and captioned "Como preparar?" (Portuguese for "How to prepare?"), which suggests it may have been intended to explain how to prepare a GLP-1 injectable medication. But whatever the intent was, the audio captured here is either severely distorted, auto-translated beyond recognition, or simply not coherent enough to evaluate. Viewers who came to this video looking for real guidance on semaglutide, tirzepatide, or any other GLP-1 agonist would have walked away with nothing useful, and possibly confused.

Does the science back this up?

There is no science to evaluate here, because there are no coherent claims. That said, the implied topic, preparing a GLP-1 injectable at home, is worth addressing directly, because it is a real question patients ask and one where bad information causes real harm.

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are administered subcutaneously, typically in the abdomen, thigh, or upper arm. Preparation steps vary by formulation. FDA-approved auto-injector pens are designed for single-patient use with minimal preparation. Compounded versions, which are vials requiring reconstitution with bacteriostatic water, involve more steps and carry a higher risk of dosing error or contamination if prepared incorrectly. The FDA has flagged compounded semaglutide safety concerns in multiple communications between 2023 and 2024, including risks from improper reconstitution and mislabeled concentrations (FDA, 2024, MedWatch).

What did they get wrong (or right)?

The creator cannot be credited with getting anything right or wrong here, because no intelligible factual claim was made. What the video does wrong is more structural: presenting incomprehensible audio under an educational hashtag on a health topic that affects patients making real decisions about injectable medications.

If the original content was in Portuguese and was auto-transcribed or machine-translated into this garbled English, that is a platform and localization failure, not necessarily the creator's fault. But the outcome is the same: a video categorized as GLP-1 education that delivers zero usable information. In a space where patients are already confused about pen vs. vial, unit vs. milligram dosing, and brand vs. compounded formulations, content that adds noise without signal is not neutral. It is a problem. Misinformation researchers have documented that health content with authoritative framing but low informational value still increases viewer confidence in incorrect beliefs (Swire-Thompson et al., 2020, Current Opinion in Psychology).

What should you actually know?

If you are trying to learn how to prepare a GLP-1 injection, skip TikTok and go to your prescribing clinician or pharmacist. That is not a dismissal of patient education online. It is an acknowledgment that injection preparation is a procedural skill with real safety stakes.

For FDA-approved pens: store per manufacturer instructions, check the expiration date, prime if required, rotate injection sites, and never share devices. For compounded vials: reconstitution should be demonstrated by a licensed pharmacist or clinician, not a social media post. Bacteriostatic water concentration matters. Syringe gauge matters. Injection depth matters. A 2023 report from the Institute for Safe Medication Practices documented multiple adverse events tied to patients self-preparing compounded semaglutide without adequate instruction (ISMP, 2023). The consequences ranged from subtherapeutic dosing to severe hypoglycemia in patients who also used insulin.

Regulated telehealth platforms like FormBlends are required to provide this guidance through licensed clinical staff, not influencer content. If your education on GLP-1 injection prep is coming from a 60-second video with incoherent audio, that is a gap worth filling through a legitimate clinical channel.